Tamsin Morris
About
Tamsin Morris is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Tamsin Morris has authored 24 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Tamsin Morris's work include Diabetes Treatment and Management (7 papers), Asthma and respiratory diseases (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Tamsin Morris is often cited by papers focused on Diabetes Treatment and Management (7 papers), Asthma and respiratory diseases (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Tamsin Morris collaborates with scholars based in United Kingdom, France and United States. Tamsin Morris's co-authors include Jennifer K Quint, Amitava Banerjee, Jil Billy Mamza, Annalisa Rubino, Yang Xu, Hana Müllerová, Enrico De Nigris, Hannah Whittaker, Ruiqi Zhang and Precil Varghese and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and European Heart Journal.
In The Last Decade
Tamsin Morris
23 papers receiving 270 citations
Peers
Tamsin Morris
Osamu Soma Japan
Kyle White Australia
Elise Chia‐Hui Tan Taiwan
Evan Davies United States
Paul Cascagnette Canada
Leon Hsueh United States
João Victor Salgado Brazil
Κonstantinos Bartziokas Greece
Xuewei Huang China
Yiyang Zhao China
Citations per year, relative to Tamsin Morris Tamsin Morris (= 1×)
peers
Osamu Soma
Countries citing papers authored by Tamsin Morris
Since
Specialization
Citations
This map shows the geographic impact of Tamsin Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamsin Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamsin Morris more than expected).
Fields of papers citing papers by Tamsin Morris
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Tamsin Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamsin Morris. The network helps show where Tamsin Morris may publish in the future.
Co-authorship network of co-authors of Tamsin Morris
This figure shows the co-authorship network connecting the top 25 collaborators of Tamsin Morris. A scholar is included among the top collaborators of Tamsin Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamsin Morris. Tamsin Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Pasea, Laura, Mohamed Mohamed, Anish Bhuva, et al.. (2025). Missed opportunities to manage complex comorbidity of heart failure, type 2 diabetes mellitus and chronic kidney disease: a retrospective cohort study. Heart. 111(16). 776–785.
2.
Jackson, David J., Hassan Burhan, Hitasha Rupani, et al.. (2024). Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two‐Year Real‐World Data With Benralizumab. Clinical & Experimental Allergy. 54(10). 734–746.
3.
Mizani, Mehrdad A., Laura Pasea, Kamlesh Khunti, et al.. (2024). Identifying subtypes of type 2 diabetes mellitus with machine learning: development, internal validation, prognostic validation and medication burden in linked electronic health records in 420 448 individuals. BMJ Open Diabetes Research & Care. 12(3). e004191–e004191.
4.
Hutchinson, Anne, Richard Russell, Omar S. Usmani, et al.. (2024). Exploring patients’ and carers’ experiences, understandings and expectations of COPD exacerbations:an interview study. BJGP Open. 9(2). BJGPO.2024.0026–BJGPO.2024.0026.
5.
Morris, Tamsin, et al.. (2024). Characteristics and outcomes of patients enrolled in the Connect 360 benralizumab patient support programme in the UK: a retrospective cohort study. BMJ Open Respiratory Research. 11(1). e001734–e001734.
6.
Crooks, Michael G., Judith Cohen, Chao Huang, et al.. (2023). Improving asthma care through implementation of the SENTINEL programme: findings from the pilot site. ERJ Open Research. 9(3). 685–2022.
7.
Pasea, Laura, Mehrdad A. Mizani, Anish Bhuva, et al.. (2023). Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study. Open Heart. 10(2). e002332–e002332.
8.
Mizani, Mehrdad A., Laura Pasea, Spiros Denaxas, et al.. (2023). Identifying subtypes of chronic kidney disease with machine learning: development, internal validation and prognostic validation using linked electronic health records in 350,067 individuals. EBioMedicine. 89. 104489–104489.
9.
Whittaker, Hannah, Annalisa Rubino, Hana Müllerová, et al.. (2022). Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study. SHILAP Revista de lepidopterología.
10.
Mizani, Mehrdad A., Spiros Denaxas, Dorothea Nitsch, et al.. (2022). A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease. Kidney International. 102(3). 652–660.
11.
Jackson, David J., Hassan Burhan, Andrew Menzies‐Gow, et al.. (2022). Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use. The Journal of Allergy and Clinical Immunology In Practice. 10(6). 1534–1544.e4.
12.
Zhang, Ruiqi, Jil Billy Mamza, Tamsin Morris, et al.. (2022). Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals. BMC Medicine. 20(1). 63–63.
13.
Whittaker, Hannah, Clémentine Nordon, Annalisa Rubino, et al.. (2022). Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study. Thorax. 78(8). 760–766.
14.
Idris, Iskandar, Ruiqi Zhang, Jil Billy Mamza, et al.. (2022). Significant reduction in chronic kidney disease progression with sodium‐glucose cotransporter‐2 inhibitors compared to dipeptidyl peptidase‐4 inhibitors in adults with type 2 diabetes in a UK clinical setting: An observational outcomes study based on international guidelines for kidney disease. Diabetes Obesity and Metabolism. 24(11). 2138–2147.
15.
Mizani, Mehrdad A., Spiros Denaxas, Dorothea Nitsch, et al.. (2021). Predicting and Validating Risk of Pre-Pandemic and Excess Mortality in Individuals With Chronic Kidney Disease. SSRN Electronic Journal.
16.
Kerkhof, Marjan, Isha Chaudhry, Ian Pavord, et al.. (2020). Blood eosinophil count predicts treatment failure and hospital readmission for COPD. ERJ Open Research. 6(4). 188–2020.
17.
Lord, Rosemary, Tamsin Morris, Rachel Jones, et al.. (2020). Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors. International Journal of Gynecological Cancer. 30(7). 1026–1033.
18.
Mamza, Jil Billy, Tamsin Morris, Folkert W. Asselbergs, et al.. (2020). Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473399 individuals. European Heart Journal. 41(Supplement_2).
19.
Jackson, Alice M., Ruiqi Zhang, Iain Findlay, et al.. (2019). Healthcare disparities for women hospitalized with myocardial infarction and angina. European Heart Journal - Quality of Care and Clinical Outcomes. 6(2). 156–165.
20.
Findlay, Iain, Tamsin Morris, Ruiqi Zhang, et al.. (2018). Linking hospital patient records for suspected or established acute coronary syndrome in a complex secondary care system: a proof-of-concept e-registry in National Health Service Scotland. European Heart Journal - Quality of Care and Clinical Outcomes. 4(3). 155–167.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Osamu Soma Breakdown of academic impact, for papers by Kyle White Breakdown of academic impact, for papers by Elise Chia‐Hui Tan Breakdown of academic impact, for papers by Evan Davies Breakdown of academic impact, for papers by Paul Cascagnette Breakdown of academic impact, for papers by Leon Hsueh Breakdown of academic impact, for papers by João Victor Salgado Breakdown of academic impact, for papers by Κonstantinos Bartziokas Breakdown of academic impact, for papers by Xuewei Huang Breakdown of academic impact, for papers by Yiyang Zhao